Vicarious Surgical Inc.
Data quality: 83%
$0.70
▼
$0.07
(-8.50%)
Mkt Cap: 4.99 M
Price
$0.70
Mkt Cap
4.99 M
Day Range
$0.70 — $0.76
52-Week Range
$0.27 — $13.75
Volume
2,607
Open $0.76
50D / 200D Avg
$1.45
51.74% below
50D / 200D Avg
$4.61
84.80% below
Quick Summary
Key Takeaways
Negative free cash flow of -45.21 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-270.15%
Below sector avg (-53.41%)
ROIC-127.56%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio4.75
Interest CoverageN/A
Valuation
PE (TTM)
-0.10
Above sector avg (-1.48)
P/B Ratio0.35
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.1 | -1.5 |
| P/B | 0.4 | 1.6 |
| ROE % | -270.2 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
ETFs Holding This Stock
0.00% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -50.18 M |
| ROE | -270.15% | ROA | -142.89% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -45.21 M |
| ROIC | -127.56% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4.75 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 11.90 M | Tangible Book Value | 14.09 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.10 | Forward P/E | N/A |
| P/B Ratio | 0.35 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -906.53% | ||
| Market Cap | 4.99 M | Enterprise Value | 1.82 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -6.35 | OCF / Share | -6.33 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 90.09% |
| SBC-Adj. FCF | -55.18 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -50.18 M | -63.22 M | -71.07 M | 5.16 M | -161,178.0 |
| EPS (Diluted) | — | — | -0.49 | 0.04 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -50.03 M | -66.56 M | -80.67 M | -80.08 M | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 33.60 M | 40.16 M | 47.58 M | 43.90 M | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | 25,000.0 | 25,000.0 | 200,000.0 | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 19.58 M | 67.72 M | 119.86 M | 140.29 M | 346.42 M |
| Total Liabilities | 9.74 M | 21.02 M | 21.90 M | 29.25 M | 12.20 M |
| Shareholders' Equity | 9.84 M | 46.70 M | 97.97 M | 111.05 M | 5.00 M |
| Total Debt | — | — | 2.00 M | 2.18 M | — |
| Cash & Equivalents | 2.57 M | 9.74 M | 52.82 M | 116.21 M | 1.10 M |
| Current Assets | 11.58 M | 51.70 M | 100.95 M | 120.40 M | 1.23 M |
| Current Liabilities | 3.90 M | 7.67 M | 7.28 M | 8.39 M | 126,220.0 |
{"event":"ticker_viewed","properties":{"ticker":"RBOT","listing_kind":"stock","pathname":"/stocks/rbot","exchange":"OTC","country":"US"}}
